The global medical physics market size was valued at USD 5.53 billion in 2025 and is projected to grow from USD 5.88 billion in 2026 to USD 9.66 billion by 2034, registering a CAGR of 6.4% during the forecast period from 2026 to 2034. North America dominated the medical physics market with a market share of 38.6% in 2025.
Medical physics is the branch of applied physics that focuses on the use of radiation, imaging technologies, and physics principles in medicine. It supports the diagnosis and treatment of diseases through technologies such as X-ray, CT, MRI, ultrasound, nuclear medicine, and radiation therapy. Growing demand for advanced diagnostic imaging and cancer treatment is driving the growth of the medical physics market.
Download a Free Sample To learn more about this report,
Integration of Artificial Intelligence in Medical Physics Workflows
The medical physics market analysis shows that healthcare facilities handle large volumes of imaging and treatment data, which encourages medical physicists to use artificial intelligence for image processing, treatment planning, dose optimization, and quality assurance. This transition is making medical physics workflows more data-driven and automated, resulting in faster analysis and more consistent support for clinical decision-making. For example, AI-based treatment-planning systems can identify anatomical structures and assist with radiation dose calculations, reducing the amount of manual work required from medical physics teams.
Advancement of Radiation Protection Technologies for Interventional Procedures
The increasing use of fluoroscopy and other image-guided procedures is creating greater attention to radiation exposure for patients and healthcare professionals, which supports the development of improved shielding, dosimetry, and real-time exposure monitoring technologies. This transition is strengthening radiation safety practices in interventional environments, resulting in better monitoring and control of cumulative radiation exposure. For example, real-time electronic dosimeters can provide immediate dose readings to interventional staff, while modern ceiling-suspended shields and table-mounted barriers provide additional protection during fluoroscopic procedures.
Diagnostic Imaging and Equipment Quality Assurance Drive Market
The wider use of CT, MRI, X-ray, and nuclear medicine procedures creates steady demand for medical physics services and quality assurance support. Healthcare facilities require physicists to assess image quality, calibrate equipment, and optimize imaging protocols for reliable results. For example, CT departments use phantom-based testing to verify image quality and radiation output during routine equipment checks. This broader imaging activity supports recurring demand for medical physicists, testing instruments, and quality assurance services.
The need for accurate and consistent medical equipment performance creates continuous requirements for calibration and quality assurance services. Hospitals and diagnostic centers rely on medical physicists to verify radiation output, imaging accuracy, and equipment stability. For example, linear accelerators used in radiation therapy undergo regular dosimetry checks to confirm that prescribed radiation doses are delivered accurately. These recurring checks support demand for dosimeters, phantoms, QA systems, and specialized medical physics services.
High Equipment Costs and Radiation Safety Regulations Restrain Market Expansion
High costs of advanced imaging, radiation therapy, dosimetry, and quality assurance equipment increase the capital investment required by healthcare facilities. These expenses can limit purchases among hospitals with constrained budgets and delay upgrades to newer medical physics technologies. The resulting investment barrier slows equipment adoption and restricts market expansion.
Stringent radiation safety standards, licensing procedures, equipment testing, and quality assurance requirements increase compliance obligations for healthcare facilities. These requirements add time, administrative effort, and operational costs to the deployment and use of radiation-based technologies. The higher compliance burden can delay technology adoption and slow market growth.
Proton Therapy Infrastructure and Physicist Training Services Offer Growth Opportunities
Medical physics companies, cancer centers, and radiation therapy providers can support proton and heavy-ion facilities through commissioning, treatment planning, dosimetry, and technical services. These capabilities create revenue through infrastructure projects and specialized service contracts, with IBA and Varian supporting particle therapy systems. Such investments can further offer growth opportunities for the medical physics market.
Training and Certification Services for Medical Physicists: Medical physics training providers, professional organizations, and healthcare institutions can offer specialized education, certification preparation, and continuing professional development programs. These services create recurring revenue through course fees and institutional training contracts, with IAEA and AAPM supporting professional education. Such services can further offer growth opportunities for the medical physics market.
Qualified Physicist Shortages and Rapid Technological Evolution Hinder Growth
Growing demand for radiation therapy, diagnostic imaging, and nuclear medicine is increasing the need for specialized medical physics expertise. Workforce shortages can limit the number of facilities able to commission and operate advanced systems, slowing service expansion. This also increases workloads for existing professionals and can delay the adoption of new medical physics technologies.
Continuous advances in radiotherapy, imaging, dosimetry, and treatment-planning technologies require healthcare providers to regularly update their systems and workflows. Frequent technology changes increase training and integration requirements for medical facilities. This can slow implementation and make it difficult for providers to keep pace with new medical physics solutions.
The diagnostic modality segment accounted for a share of 64.7% in 2025, owing to the widespread use of diagnostic imaging technologies, increasing demand for accurate disease detection, and growing adoption of advanced imaging systems. the rising volume of diagnostic procedures and continued integration of medical physics expertise in imaging quality assurance further strengthen the segment’s dominant position in the medical physics market.
The therapeutic modality segment is expected to grow at a CAGR of 7.11% during the forecast period, driven by increasing adoption of radiation therapy, advancements in cancer treatment technologies, and growing demand for precise and personalized therapeutic procedures. the development of advanced radiotherapy techniques and increasing investments in cancer treatment infrastructure further support the segment’s growth in the medical physics market.
Request Customizationto receive a tailored report.
The x-ray segment accounted for a share of 19.6% in 2025 due to its widespread use in diagnostic imaging, cost-effectiveness, established clinical infrastructure, and ability to support rapid disease detection. the continued demand for routine radiographic examinations and advancements in digital x-ray systems further strengthen the segment’s dominant position in the medical physics market. the increasing integration of automated image analysis, dose optimization, and quality assurance technologies in x-ray imaging further supports segment demand across healthcare facilities.
The nuclear medicine segment is expected to grow at a CAGR of 7.38% during the forecast period, fueled by increasing adoption of molecular imaging, rising demand for early disease detection, and advancements in nuclear diagnostic technologies. the computed tomography segment supports detailed cross-sectional imaging, the magnetic resonance imaging segment enables high-resolution soft-tissue visualization, and the ultrasound segment provides accessible real-time imaging. the mammography segment serves breast cancer screening and diagnostic applications, while the others segment covers additional diagnostic modalities used across healthcare settings.
The external beam radiation therapy segment accounted for a share of 48.2% in 2025, supported by its widespread use in cancer treatment, established clinical infrastructure, and ability to deliver precise radiation doses to targeted tumor sites. the continued adoption of advanced linear accelerators, intensity-modulated radiation therapy, and image-guided treatment techniques further strengthens the segment’s dominant position in the medical physics market.
The proton therapy segment is expected to grow at a CAGR of 8.74% during the forecast period, propelled by increasing demand for highly precise radiation treatment, growing adoption of advanced cancer therapies, and expanding investments in proton therapy infrastructure. the brachytherapy segment supports localized radiation treatment through direct placement of radioactive sources near tumors, while the stereotactic radiosurgery segment benefits from increasing use of highly focused radiation techniques for treating tumors and other neurological conditions. the others segment includes additional therapeutic modalities that contribute to the broader adoption of medical physics technologies across specialized treatment settings.
The gel segment accounted for a share of 34.8% in 2025, owing to its widespread use in medical applications, ease of handling, and suitability for delivering and supporting therapeutic and diagnostic procedures. the established use of gel-based formulations across healthcare settings and continued demand for effective treatment materials further strengthen the segment’s dominant position in the medical physics market.
The paste & putty segment is expected to grow at a CAGR of 7.24% during the forecast period, driven by increasing demand for versatile medical formulations, expanding applications in specialized procedures, and growing adoption of advanced treatment materials. the granules segment supports applications requiring controlled material handling and formulation flexibility, while the others segment includes additional forms used across diverse medical and healthcare applications.
The hospitals segment accounted for a share of 46.7% in 2025 due to their extensive use of medical physics services, advanced diagnostic and therapeutic equipment, and large patient volumes requiring imaging and radiation-based procedures. the continued expansion of hospital infrastructure and increasing adoption of advanced medical technologies further strengthen the segment’s dominant position in the medical physics market.
The cancer treatment centers segment is expected to grow at a CAGR of 7.42% during the forecast period, fueled by rising cancer incidence, increasing adoption of advanced radiation therapy techniques, and growing demand for precise and personalized cancer treatment. the diagnostic imaging centers segment supports increasing demand for specialized imaging procedures and quality assurance services, while the academic & research institutes segment contributes through medical physics research, education, and technology development.
Speak to an Analystto discuss market opportunities.
The North America medical physics market accounted for the largest regional share of 38.6% in 2025, driven by advanced healthcare infrastructure, high adoption of medical imaging and radiation therapy technologies, and strong demand for specialized medical physics services. The U.S. medical physics market is expected to benefit from ongoing efforts to improve cancer outcomes, as the U.S. Healthy People 2030 target aims to reduce the overall cancer death rate to 122.7 deaths per 100,000 people, while the National Cancer Institute continues to fund research integrating advanced radiation technologies and clinical practice, supporting future demand for medical physics expertise in radiation oncology and treatment planning.
The Canada medical physics market is supported by advancements in radiation therapy and nuclear medicine, as the National Research Council is developing measurement standards for emerging FLASH radiotherapy, which can deliver a radiation dose in less than 1 second, while Ontario is targeting a doubling of medical isotope production by 2030, supporting future demand for medical physics, dosimetry, radiation measurement, and nuclear medicine capabilities.
Unlock Regional Insightsto access country-level data, & regional trends.
The Asia Pacific medical physics market is expected to grow at a CAGR of 8.12%, showcasing the fastest-growing regional market, supported by expanding healthcare infrastructure, increasing adoption of advanced diagnostic and therapeutic technologies, and rising investments in cancer care. Japan’s medical physics market is expected to benefit from the government’s ongoing development of its Third Basic Plan for Medical Devices, with Japan’s Ministry of Health, Labour and Welfare continuing consultations in 2026 on research, development, and wider adoption of advanced medical devices, including technologies relevant to radiation-based diagnosis and treatment.
China’s medical physics market is supported by continued investment in radiation-treatment infrastructure, with a RMB 30 million budget allocated in April 2026 for centralized procurement of medical linear accelerators, while another national procurement of X-ray stereotactic radiosurgery systems recorded a total transaction value of RMB 111 million in February 2026. South Korea’s medical physics market is expected to benefit from the government’s planned expansion of advanced cancer-treatment infrastructure, with the Ministry of Health and Welfare allocating KRW 74.2 billion in 2026 to regional tertiary-care institutions for critical-care facilities and advanced medical equipment, including support for introducing proton therapy equipment at Chilgok Kyungpook National University Hospital. India’s medical physics market is supported by the government’s ₹3,420 crore Production Linked Incentive Scheme for Medical Devices, which covers cancer-care/radiotherapy and radiology/imaging devices; 27 projects had been approved, with ₹1,153.07 crore in actual investment and domestic production already started for products including LINACs, MRI, CT, and other advanced medical equipment.
The Europe medical physics market accounted for a regional share of 29.4% in 2025, supported by established healthcare systems, widespread use of advanced medical technologies, and increasing demand for quality assurance and radiation safety services. In the U.K. medical physics market, the government’s £70 million investment in new linear accelerator (LINAC) machines across 28 hospitals is expected to support up to 27,500 additional radiotherapy treatments annually by March 2027, while the 10-year NHS capital plan will raise the health capital budget to £15 billion by 2029–30, supporting continued modernization of medical-physics and radiotherapy infrastructure.
In the Germany medical physics market, the 2026 radiotherapy planning framework highlights increasing adoption of online adaptive radiotherapy (oART), with oART-capable systems requiring substantially higher acquisition and maintenance costs than conventional linear accelerators, as well as additional medical-physics expertise and IT infrastructure, supporting demand for advanced medical-physics technologies. Meanwhile, the France medical physics market is supported by the country’s regulatory framework, which requires medical physicists to contribute to radiotherapy, nuclear medicine, and medical imaging, including radiation-exposure optimization, equipment selection, quality assurance, and equipment quality control, supporting continued demand for medical-physics expertise and related technologies.
The Middle East and Africa medical physics market is expected to grow at a CAGR of 5.86%, supported by improving healthcare infrastructure, expanding access to advanced diagnostic and radiation therapy technologies, and growing investments in specialized healthcare services. The UAE medical physics market is expected to benefit from the UAE’s first dedicated proton therapy centre in Dubai, with construction scheduled to begin in Q1 2026 and operations targeted by the end of 2028. The facility will provide advanced proton therapy for cancer treatment, supporting future demand for medical physics expertise in radiation treatment planning, dosimetry, and radiation safety.
The Africa medical physics market is expected to benefit from continued investment in radiotherapy infrastructure and workforce development, with the IAEA reporting that four radiotherapy and two brachytherapy bunkers were completed in Malawi and equipment including two linear accelerators was procured, while services were scheduled to begin in 2025. The IAEA is also supporting medical-physics training to build the skilled workforce required for these facilities.
The medical physics market is moderately fragmented, with medical equipment manufacturers, radiation therapy technology providers, diagnostic imaging companies, healthcare technology firms, specialized medical physics solution providers, and regional service companies competing across clinical and research applications. Established players compete primarily on technological innovation, equipment accuracy, safety, reliability, regulatory compliance, product performance, application expertise, service capabilities, global distribution networks, and long-term relationships with healthcare institutions, with leading players such as Varian Medical Systems, Elekta, Siemens Healthineers, GE HealthCare, and Philips Healthcare estimated to account for approximately 45% of the global market based on their scale, product portfolios, technological capabilities, geographic presence, and competitive positioning.
Emerging and regional players within the medical physics market ecosystem compete through cost-effective solutions, specialized applications, customized services, localized support, flexible offerings, rapid response, and integration of advanced technologies to address specific clinical requirements and strengthen their market presence. these players also focus on developing application-specific solutions, improving interoperability with existing healthcare systems, and expanding partnerships with hospitals and research institutions to broaden their customer base.
Customize This Report to Match Your Strategic Objectives
Author's Details
Healthcare Lead
Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, competitive dynamics, and market opportunities. Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.
Otoplasty Market Size, Share, Growth, Analysis, Report, 2034
Medical Devices Reimbursement Market Size, Share, Growth, 2034
Real World Evidence Solutions Market Size, Share, 2034
Surrogacy Market Size, Share, Growth, Analysis, Report, 2034
Viral Vector Manufacturing Market Size, Share, Growth, Analysis, 2034
Healthcare Staffing Market Size, Share, Growth, Analysis, 2034
We are featured on:
sales@straitsresearch.com